Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Raloxifene hydrochloride for peak identification

Raloxifene hydrochloride for peak identification is listed in the pharmaceutical impurity collection under CAS 82640-04-8. Its represented structure has formula C28H28ClNO4S and a calculated molecular weight of 510.06 g/mol.

2D chemical structure

H C l O O N O H S O H

Chemical identity

Catalog name
Raloxifene hydrochloride for peak identification
Common name
Raloxifene hydrochloride for peak identification
Chemical name
[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride
CAS
82640-04-8
SMILES
Cl.O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12
InChI
InChI=1S/C28H27NO4S.ClH/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29;/h4-13,18,30-31H,1-3,14-17H2;1H
InChIKey
BKXVVCILCIUCLG-UHFFFAOYSA-N
Associated API
raloxifene

Record ID: Ab2917b8580be

Computed properties

C28H28ClNO4S Molecular formula
510.055 g/molMolecular weight
509.1428 DaMonoisotopic exact mass
70 ŲTopological polar surface area
6.497 Calculated LogP (Wildman–Crippen)
143.4991 cm³/molMolar refractivity (Wildman–Crippen)
6 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. The SMILES contains 2 disconnected components. Calculations retain all represented components.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N O S 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight510.05586.11
Calculated LogP (Wildman–Crippen)6.49796.13
Topological polar surface area7049.95
Hydrogen-bond acceptors675.83
Hydrogen-bond donors264.87
Rotatable bonds (strict)776.94

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC28H28ClNO4Sdimensionless
Molecular weight510.055g/mol
Monoisotopic exact mass509.1428Da
Topological polar surface area70Ų
Calculated LogP (Wildman–Crippen)6.497dimensionless
Molar refractivity (Wildman–Crippen)143.4991cm³/mol
Hydrogen-bond acceptors6count
Hydrogen-bond donors2count
Rotatable bonds (strict)7count
Heavy atoms35count
Heteroatoms7count
Rings5count
Aromatic rings4count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles1count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles3count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.25fraction
Formal charge0e
Disconnected components2count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area214.5578Ų
Valence electrons182count
Radical electrons0count
Bertz complexity1,295.294index
Balaban J0index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Raloxifene hydrochloride for peak identification

Qualification and safety assessment of Raloxifene hydrochloride for peak identification

Explore toxicological qualification of Raloxifene hydrochloride for peak identification and ICH M7 mutagenic impurity assessment of Raloxifene hydrochloride for peak identification for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Raloxifene hydrochloride for peak identification and acceptable intake and limit justification for Raloxifene hydrochloride for peak identification. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Raloxifene hydrochloride for peak identification

Explore Altox services and software through the Altox Pharma-Hub.